The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Schellenberg Wittmer Ltd

LĂ–WENSTRASSE 19, PO BOX 1876, 8021 ZĂśRICH, SWITZERLAND
Tel:
Work +41 44 215 52 52
Fax:
Fax +41 44 215 52 00
Email:
Web:
www.swlegal.ch
Geneva, Singapore, Zurich

Josef Caleff

Tel:
Work +41 44 215 5252
Email:
Web:
www.swlegal.ch/en/lawyers/lawyer-detail/josef-caleff/
Schellenberg Wittmer Ltd

Work Department

Zurich / Real Estate Law / Construction / Mergers & Acquisitions / Corporate and Commercial / Private Equity and Venture Capital / Hotels and Leisure / Real Estate Industry

Position

Josef Caleff heads Schellenberg Wittmer's Real Estate Group in Zurich and is a partner in the Construction Group as well as the Mergers & Acquisitions Group. He advises clients in all types of corporate and M&A transactions and possesses special expertise in real estate transactions, in particular sale and purchase of single properties and portfolios, real estate financing, construction and commercial leases.

Career

Associate at Schellenberg Wittmer (2004), Partner (2011). Member of the Management Committee (2014).

Languages

German, English, French.

Member

IBA.

Education

University of St. Gallen, Economics degree (1996), Law degree (1999). Swiss bar (2002). University of California Hastings, Law degree (2004). New York bar (2006). Certified Specialist SBA Construction and Real Estate Law (2013).


Switzerland

Real estate and construction

Within: Real estate and construction

The 'reactive, available and helpful' real estate practice at Schellenberg Wittmer Ltd is known for its international expertise in all aspects of real estate contracts, transactions, construction, environmental law, special rights, owner's liability, financing and dispute resolution. Yves Jeanrenaud, who provides 'accurate and precise' advice, assisted DuPont de Nemours International and Credit Suisse with the due diligence required for the simultaneous disposal of land and building reconstruction in relation to three office buildings constructed on the land. Josef Caleff advised Barana Group on the sale of a large retail building in Lucerne to a Swiss institutional investor via a structured, two-stage auction process.

[back to top]


Back to index

Legal Developments in Switzerland

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • Bär & Karrer Awarded "Law Firm of the Year - Switzerland" at the Citywealth Magic Circle Awards 201

    Bär & Karrer is pleased to announce that it has received the award “Law Firm of the Year - Switzerland” at the Citywealth Magic Circle Awards in London. This award recognizes Bär & Karrer as the Swiss law firm with the best private client team.
  • Bär & Karrer Advises Ashcroft on the Acquisition of RĂĽeger Holding

    Ashcroft Inc., headquartered in Stratford, CT, USA, a subsidiary of Tokyo Stock Exchange listed Nagano Keiki Co., Ltd, has announced the completion of the acquisition of Swiss-based RĂĽeger Holding SA (RĂĽeger) and Dutch-based STIKO Meetapparentenfabriek B.V. (Stiko), both manufacturers of specialty temperature and pressure measurement products, from their previous owners, Bernard and Jean-Marc RĂĽeger.
  • Ordinance on Integrity and Transparency in the Therapeutic Products Sector has been adopted

    Click here for more information.
  • Bär & Karrer Advises B3i in its Current Equity Funding Round

    Industry-led InsurTech B3i Services AG successfully raised additional funds from current shareholders and new investors to further develop and grow its blockchain-based insurance transaction platform. B3i was founded in October 2016 as an insurance industry consortium which then formed B3i Services AG as an independent company. The shareholder group includes some of the world's largest insurers and reinsurers from across Europe, the Americas, and Asia. B3i intends to further expand its shareholder base over the next several months.
  • Bär & Karrer Continues to Grow Finance and Sports Practice with Two New Partners

    Bär & Karrer is pleased to announce that it further strengthens its Financing and Sports practices with new partners Lukas Roesler and Dr. Jan Kleiner, both of whom have worked with the firm previously.
  • Bär & Karrer Advises Novartis and Alcon on the Spin-off of Alcon

    Today, Novartis AG completed the spin-off of the Alcon eye care devices business, and Alcon Inc. debuted as independent publicly traded company. The Alcon shares were successfully listed on the SIX Swiss Exchange Ltd. and the New York Stock Exchange. They are also included in the Swiss Market Index (SMI), which comprises the 20 largest Swiss listed stocks.
  • Bär & Karrer Advises Primeo Energie and CSA Energie-Infrastructure Schweiz in Aquisition from ElĂ©t

    Primeo Energie, EOS Holding SA (EOS) and Électricité de France (EDF) have entered into a share purchase agreement relating to the purchase by Primeo Energie and EOS of the 25% interest held by EDF in Alpiq Holding SA. The purchase by Primeo Eergie and EOS will be financed through mandatory exchangeable loan agreements made by CSA Energie-Infrastruktur Schweiz (CSA) as lender, the biggest investment pool for Swiss energy infrastructure with 135 Swiss pension funds acting as investors. At maturity the mandatory exchangeable loan agreements will be converted into shares in Alpiq. Primeo Energie and EOS thereby pave the way for a Swiss shareholder structure of Alpiq.
  • Bär & Karrer Awarded Most Innovative Swiss Law Firm of the Year at the IFLR Europe Awards

    Bär & Karrer was awarded „Most innovative law firm of the year - Switzerland", the national award for Switzerland given in the IFLR European Awards. The most innovative law firm of the year award recognizes Bär & Karrer as the Swiss law firm with the best track record in 2018 giving advice on the most innovative cross-border deals covering all award practice areas. It is already the third prize of this kind in period of six years awarded to Bär & Karrer.
  • Bär & Karrer Advises DSV on Public Exchange Offer for Panalpina

    On 1 April 2019, DSV A/S, Hedehusene, Denmark and Panalpina Welttransport (Holding) AG, Zurich, Switzerland, have entered into an agreement on the terms and conditions of a combination by way of a public exchange offer by DSV for all publicly held registered shares of Panalpina for approximately CHF 4.6 billion. The board of directors of Panalpina has resolved to support the public exchange offer by DSV and to recommend the acceptance of DSV's public exchange offer to its shareholders.
  • Bär & Karrer Advises Lonza on the Entering into a Strategic Joint Venture with Chr. Hansen for Deve

    On 2 April 2019, Lonza, a leading pharma contract manufacturing company, and Chr. Hansen, a leading global bioscience company, announced that they have signed an agreement to establish a 50/50 joint venture to pioneer the live biotherapeutic products (LBPs) industry and position themselves as the leading contract development and manufacturing partner (CDMO) for biotech and pharma customers. The joint venture brings together best-in-class, complementary capabilities and will be the first CDMO globally to provide a full supply chain that offers manufacturing of bacteria strains for therapeutic use. The joint venture will be a 50/50 controlled legal entity that will operate from its headquarters in Basel (CH) and have production facilities in Denmark and Switzerland. A phased investment of approximately EUR 90 million will be deployed over three years to build cGMP-compliant pharma production capabilities. The joint venture will upgrade existing facilities in Hørsholm (DK) and equip new facilities in Basel (CH) to serve pre-clinical to phase II projects. Further facilities for phase III and commercial manufacturing will be developed as the pipeline matures. The joint venture is expected to be largely self-funding after the production set-up has been established.